Stroke Recovery in Walking, Speech, and Cognition from October 2017 to December 2017
The stroke was in February of 2016.
Request a consultation today
Disclaimer: Individual results vary, not all patients respond. Additional doses may be necessary to maintain the clinical response. Treatment is innovative (“off-label”). Terms of Use
From Iceland: Walking & Post-Stroke Pain Improvement 2 years after Stroke at the INR, Nov. 2017
From Iceland, improvement in walking and dramatic reduction in post-stroke pain after treatment at the INR in Boca Raton, Florida, two years after stroke, November 2017. One week phone follow-up appointment is included.
Request a consultation today
Disclaimer: Individual results vary, not all patients respond. Additional doses may be necessary to maintain the clinical response. Treatment is innovative (“off-label”). Terms of Use
Rapid Improvement in Post-Stroke Pain 17 months after Stroke at the INR, November 2017
Disclaimer: Individual results vary, not all patients respond. Additional doses may be necessary to maintain the clinical response. Treatment is innovative (“off-label”). Terms of Use
“My leg feels light as a feather” after treatment at the INR, 3 years after stroke October 2017
Family from Melbourne, Australia. Treatment at the Institute of Neurological Recovery in Boca Raton on October 23-30, 2017; almost 3 years after stroke. For further information, please visit strokebreakthrough.com
Disclaimer: Individual results vary, not all patients respond. Additional doses may be necessary to maintain the clinical response. Treatment for these indications is innovative (“off-label”). Please see the Terms of Use. The method of off-label treatment utilized is a patented invention of the INR. Copyright 2018 INR PLLC, all rights reserved.
Edward Tobinick, M.D., the founder and Director of the Institute of Neurological Recovery, invented the remarkable groundbreaking perispinal etanercept treatment for stroke and chronic brain injury in 2010. Now, in 2024, there have been thousands of individuals with chronic stroke symptoms successfully treated by Dr. Tobinick. Dr. Tobinick has now treated individuals from every state in the U.S. and from 102 countries.
In October 2018, the Australian Government announced their designation of substantial funding to study perispinal etanercept(PSE) for treatment of stroke. On January 3, 2020 a university, double-blind, randomized, placebo-controlled, clinical trial confirmed the efficacy of perispinal etanercept for treatment of chronic neurological symptoms after stroke. Dr. Tobinick was instrumental in the design of the university study.
Dr. Tobinick accepts patients for treatment from all parts of the world, and has treated patients from every populated continent of the world.
Scientific articles from hundreds of academic scientists around the world have cited Dr. Tobinick's scientific publications.
Comments: 0